Clinical Trials
2 trialsNCT00030355 2013-03-22
Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic Leukemia
National Cancer Institute (NCI)
Phase 1/2 Withdrawn
NCT00002574 2013-02-05
Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia
National Cancer Institute (NCI)
Phase 2 Completed